TD Cowen lowered the firm’s price target on NeoGenomics to $22 from $23 and keeps an Outperform rating on the shares. The firm said underlying drivers show no sign of slowing and Cowen sees an attractive outlook for the shares.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on NEO:
